Sale!

Opdivo

Opdivo, is a medication used to treat cancer. It is used as a first-line treatment for inoperable or metastatic melanoma in combination with ipilimumab if the cancer does not have a mutation in BRAF, as a second-line treatment following treatment with ipilimumab and if the cancer has a mutation in BRAF, with a BRAF inhibitor, as a second-line treatment for squamous non-small cell lung cancer, and as a second-line treatment for renal cell carcinoma. We help patients and doctors get access to medicines at the lowest price worldwide.

Oncology	Urothelial Carcinoma, Colorectal Cancer, Head and Neck Cancer, Kidney Cancer, Liver Cancer, Lung Cancer, Lymphoma, Skin Cancer
Mode of Action	Monoclonal antibody (immunotherapy)
Administration	Intravenous
Regulatory agency approval	European Medical Agency (EMA), European Union, Food and Drug Administration (FDA), USA, Pharmaceuticals and Medical Devices Agency (PMDA), Japan, Therapeutic Goods Administration (TGA), Australia
Strength	10 milligram / millilitre
Package	1 Vials

Description
Additional information

What is Opdivo?

Opdivo is an immuno-therapy that uses a monoclonal antibody to stimulate the body’s immune system to kill cancer cells. The cancer drug has been approved to treat a multitude of different cancers. This is for skin, lung, head and neck, bladder and classical Hodgkin lymphoma. In addition, various studies into the effectiveness of Opdivo on different cancers suggested that it extended the life of 73% of skin cancer patients. For instance, 66% of lymphoma patients and 66.5% of bladder cancer patients.

Lung Cancer

OPDIVO^® (nivolumab) is a prescription medicine used to treat people with a type of advanced stage lung cancer (called non-small cell lung cancer). This is for cancers that have spread or grown and you have tried chemotherapy that contains platinum, and it did not work or is no longer working. If your tumor has an abnormal EGFR or ALK gene, you should have also tried an FDA-approved therapy for tumors with these abnormal genes, and it did not work or is no longer working.

Skin Cancer and OPDIVO

OPDIVO^® (nivolumab) is a prescription medicine used to treat people with a type of skin cancer called melanoma. This is for those that have spread or cannot be removed by surgery (advanced melanoma).